NDTx-01 Exploratory Clinical Trial Results Published in SCIE-Indexed Journal
- Jul 6
- 1 min read
Neudive Co., Ltd. successfully completed an exploratory clinical trial to verify the initial safety and efficacy of NDTx-01 (Buddy-in), developed to improve social communication and interaction in children and adolescents (ages 10–18) with Autism Spectrum Disorder (ASD) or Social Communication Disorder (SCD). The results of the exploratory clinical trial were published on April 11, 2025 in Psychiatry and Clinical Neurosciences, an SCIE-indexed academic journal.
